Cargando…
Cancer-specific survival after radical nephroureterectomy for upper urinary tract urothelial carcinoma: proposal and multi-institutional validation of a post-operative nomogram
BACKGROUND: Owing to the scarcity of upper urinary tract urothelial carcinoma (UUT-UC) it is often necessary for investigators to pool data. A patient-specific survival nomogram based on such data is needed to predict cancer-specific survival (CSS) post nephroureterectomy (NU). Herein, we propose an...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3304431/ https://www.ncbi.nlm.nih.gov/pubmed/22374463 http://dx.doi.org/10.1038/bjc.2012.64 |
_version_ | 1782226902380969984 |
---|---|
author | Yates, D R Hupertan, V Colin, P Ouzzane, A Descazeaud, A Long, J A Pignot, G Crouzet, S Rozet, F Neuzillet, Y Soulie, M Bodin, T Valeri, A Cussenot, O Rouprêt, M |
author_facet | Yates, D R Hupertan, V Colin, P Ouzzane, A Descazeaud, A Long, J A Pignot, G Crouzet, S Rozet, F Neuzillet, Y Soulie, M Bodin, T Valeri, A Cussenot, O Rouprêt, M |
author_sort | Yates, D R |
collection | PubMed |
description | BACKGROUND: Owing to the scarcity of upper urinary tract urothelial carcinoma (UUT-UC) it is often necessary for investigators to pool data. A patient-specific survival nomogram based on such data is needed to predict cancer-specific survival (CSS) post nephroureterectomy (NU). Herein, we propose and validate a nomogram to predict CSS post NU. PATIENTS AND METHODS: Twenty-one French institutions contributed data on 1120 patients treated with NU for UUT-UC. A total of 667 had full data for nomogram development. Study population was divided into the nomogram development cohort (397) and external validation cohort (270). Cox proportional hazards regression models were used for univariate and multivariate analyses and to build a nomogram. A reduced model selection was performed using a backward step-down selection process, and Harrell's concordance index (c-index) was used for quantifying the nomogram accuracy. Internal validation was performed by bootstrapping and the reduced nomogram model was calibrated. RESULTS: Of the 397 patients in the nomogram development cohort, 91 (22.9%) died during follow-up, of which 66 (72.5%) died as a consequence of UUT-UC. The actuarial CSS probability at 5 years was 0.76 (95% CI, 71.62-80.94). On multivariate analysis, T stage (P<0.0001), N status (P=0.014), grade (P=0.026), age (P=0.005) and location (P=0.022) were associated with CSS. The reduced nomogram model had an accuracy of 0.78. We propose a nomogram to predict 3 and 5-year CSS post NU for UUT-UC. CONCLUSION: We have devised and validated an accurate nomogram (78%), superior to any single clinical variable or current model, for predicting 5-year CSS post NU for UUT-UC. |
format | Online Article Text |
id | pubmed-3304431 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | Nature Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-33044312013-03-13 Cancer-specific survival after radical nephroureterectomy for upper urinary tract urothelial carcinoma: proposal and multi-institutional validation of a post-operative nomogram Yates, D R Hupertan, V Colin, P Ouzzane, A Descazeaud, A Long, J A Pignot, G Crouzet, S Rozet, F Neuzillet, Y Soulie, M Bodin, T Valeri, A Cussenot, O Rouprêt, M Br J Cancer Clinical Study BACKGROUND: Owing to the scarcity of upper urinary tract urothelial carcinoma (UUT-UC) it is often necessary for investigators to pool data. A patient-specific survival nomogram based on such data is needed to predict cancer-specific survival (CSS) post nephroureterectomy (NU). Herein, we propose and validate a nomogram to predict CSS post NU. PATIENTS AND METHODS: Twenty-one French institutions contributed data on 1120 patients treated with NU for UUT-UC. A total of 667 had full data for nomogram development. Study population was divided into the nomogram development cohort (397) and external validation cohort (270). Cox proportional hazards regression models were used for univariate and multivariate analyses and to build a nomogram. A reduced model selection was performed using a backward step-down selection process, and Harrell's concordance index (c-index) was used for quantifying the nomogram accuracy. Internal validation was performed by bootstrapping and the reduced nomogram model was calibrated. RESULTS: Of the 397 patients in the nomogram development cohort, 91 (22.9%) died during follow-up, of which 66 (72.5%) died as a consequence of UUT-UC. The actuarial CSS probability at 5 years was 0.76 (95% CI, 71.62-80.94). On multivariate analysis, T stage (P<0.0001), N status (P=0.014), grade (P=0.026), age (P=0.005) and location (P=0.022) were associated with CSS. The reduced nomogram model had an accuracy of 0.78. We propose a nomogram to predict 3 and 5-year CSS post NU for UUT-UC. CONCLUSION: We have devised and validated an accurate nomogram (78%), superior to any single clinical variable or current model, for predicting 5-year CSS post NU for UUT-UC. Nature Publishing Group 2012-03-13 2012-02-28 /pmc/articles/PMC3304431/ /pubmed/22374463 http://dx.doi.org/10.1038/bjc.2012.64 Text en Copyright © 2012 Cancer Research UK https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material.If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Clinical Study Yates, D R Hupertan, V Colin, P Ouzzane, A Descazeaud, A Long, J A Pignot, G Crouzet, S Rozet, F Neuzillet, Y Soulie, M Bodin, T Valeri, A Cussenot, O Rouprêt, M Cancer-specific survival after radical nephroureterectomy for upper urinary tract urothelial carcinoma: proposal and multi-institutional validation of a post-operative nomogram |
title | Cancer-specific survival after radical nephroureterectomy for upper urinary tract urothelial carcinoma: proposal and multi-institutional validation of a post-operative nomogram |
title_full | Cancer-specific survival after radical nephroureterectomy for upper urinary tract urothelial carcinoma: proposal and multi-institutional validation of a post-operative nomogram |
title_fullStr | Cancer-specific survival after radical nephroureterectomy for upper urinary tract urothelial carcinoma: proposal and multi-institutional validation of a post-operative nomogram |
title_full_unstemmed | Cancer-specific survival after radical nephroureterectomy for upper urinary tract urothelial carcinoma: proposal and multi-institutional validation of a post-operative nomogram |
title_short | Cancer-specific survival after radical nephroureterectomy for upper urinary tract urothelial carcinoma: proposal and multi-institutional validation of a post-operative nomogram |
title_sort | cancer-specific survival after radical nephroureterectomy for upper urinary tract urothelial carcinoma: proposal and multi-institutional validation of a post-operative nomogram |
topic | Clinical Study |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3304431/ https://www.ncbi.nlm.nih.gov/pubmed/22374463 http://dx.doi.org/10.1038/bjc.2012.64 |
work_keys_str_mv | AT yatesdr cancerspecificsurvivalafterradicalnephroureterectomyforupperurinarytracturothelialcarcinomaproposalandmultiinstitutionalvalidationofapostoperativenomogram AT hupertanv cancerspecificsurvivalafterradicalnephroureterectomyforupperurinarytracturothelialcarcinomaproposalandmultiinstitutionalvalidationofapostoperativenomogram AT colinp cancerspecificsurvivalafterradicalnephroureterectomyforupperurinarytracturothelialcarcinomaproposalandmultiinstitutionalvalidationofapostoperativenomogram AT ouzzanea cancerspecificsurvivalafterradicalnephroureterectomyforupperurinarytracturothelialcarcinomaproposalandmultiinstitutionalvalidationofapostoperativenomogram AT descazeauda cancerspecificsurvivalafterradicalnephroureterectomyforupperurinarytracturothelialcarcinomaproposalandmultiinstitutionalvalidationofapostoperativenomogram AT longja cancerspecificsurvivalafterradicalnephroureterectomyforupperurinarytracturothelialcarcinomaproposalandmultiinstitutionalvalidationofapostoperativenomogram AT pignotg cancerspecificsurvivalafterradicalnephroureterectomyforupperurinarytracturothelialcarcinomaproposalandmultiinstitutionalvalidationofapostoperativenomogram AT crouzets cancerspecificsurvivalafterradicalnephroureterectomyforupperurinarytracturothelialcarcinomaproposalandmultiinstitutionalvalidationofapostoperativenomogram AT rozetf cancerspecificsurvivalafterradicalnephroureterectomyforupperurinarytracturothelialcarcinomaproposalandmultiinstitutionalvalidationofapostoperativenomogram AT neuzillety cancerspecificsurvivalafterradicalnephroureterectomyforupperurinarytracturothelialcarcinomaproposalandmultiinstitutionalvalidationofapostoperativenomogram AT souliem cancerspecificsurvivalafterradicalnephroureterectomyforupperurinarytracturothelialcarcinomaproposalandmultiinstitutionalvalidationofapostoperativenomogram AT bodint cancerspecificsurvivalafterradicalnephroureterectomyforupperurinarytracturothelialcarcinomaproposalandmultiinstitutionalvalidationofapostoperativenomogram AT valeria cancerspecificsurvivalafterradicalnephroureterectomyforupperurinarytracturothelialcarcinomaproposalandmultiinstitutionalvalidationofapostoperativenomogram AT cussenoto cancerspecificsurvivalafterradicalnephroureterectomyforupperurinarytracturothelialcarcinomaproposalandmultiinstitutionalvalidationofapostoperativenomogram AT roupretm cancerspecificsurvivalafterradicalnephroureterectomyforupperurinarytracturothelialcarcinomaproposalandmultiinstitutionalvalidationofapostoperativenomogram |